{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:44:42Z","timestamp":1794091482219,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["2R01ES010544, R56ES026600, R21ES032593"],"award-info":[{"award-number":["2R01ES010544, R56ES026600, R21ES032593"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Depression is a common non-motor symptom of Parkinson\u2019s disease (PD), with poorly understood mechanisms. To explore whether there are dysregulated metabolic pathways among PD patients with depression, we analyzed serum samples of PD patients from a population-based case-control study (total\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009635) and performed metabolome-wide association and pathway analyses of depression in PD. We identified 212 metabolomic features associated with having ever received a depression diagnosis before PD and 213 features with higher Geriatric Depression Scale (GDS) scores (129 were annotated). Metabolic features we identified belonged to 14 pathways: glycerophospholipid metabolism for both outcomes and tryptophan, tyrosine, folate, biopterin, and sialic acid metabolism for those with higher GDS scores. An association with 6-hydroxy-1H-indole-3acetamide we observed likely indicates recent antidepressant treatment. These findings suggest that dysregulation in lipid and amino acid pathways, including tryptophan and tyrosine metabolism involved in neurotransmitter synthesis, may reflect altered neurochemical signaling and systemic metabolic changes related to depression in PD.\n                  <\/jats:p>","DOI":"10.1038\/s41531-025-01226-2","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:37:59Z","timestamp":1765453079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolomic profiles of depression in Parkinson\u2019s disease patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuyuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas I.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Duarte Folle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irish","family":"Del Rosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne M.","family":"Keener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D. & Leentjens, A. F. A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov. Disord. 23, 183\u2013189 (2008).","journal-title":"Mov. Disord."},{"key":"1226_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002512-199812010-00006","volume":"12","author":"T Tom","year":"1998","unstructured":"Tom, T. & Cummings, J. L. Depression in Parkinson\u2019s disease. Pharmacological characteristics and treatment. Drugs Aging 12, 55\u201374 (1998).","journal-title":"Drugs Aging"},{"key":"1226_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0409-5","volume":"13","author":"L Marsh","year":"2013","unstructured":"Marsh, L. Depression and Parkinson\u2019s disease: current knowledge. Curr. Neurol. Neurosci. Rep. 13, 409 (2013).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1226_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/archneur.1997.00550170097020","volume":"54","author":"E Tandberg","year":"1997","unstructured":"Tandberg, E., Larsen, J. P., Aarsland, D., Laake, K. & Cummings, J. L. Risk factors for depression in Parkinson disease. Arch. Neurol. 54, 625\u2013630 (1997).","journal-title":"Arch. Neurol."},{"key":"1226_CR5","first-page":"61","volume":"65","author":"R Brown","year":"1995","unstructured":"Brown, R. & Jahanshahi, M. Depression in Parkinson\u2019s disease: a psychosocial viewpoint. Adv. Neurol. 65, 61\u201384 (1995).","journal-title":"Adv. Neurol."},{"key":"1226_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","volume":"16","author":"EL Jacob","year":"2010","unstructured":"Jacob, E. L., Gatto, N. M., Thompson, A., Bordelon, Y. & Ritz, B. Occurrence of depression and anxiety prior to Parkinson\u2019s disease. Park. Relat. Disord. 16, 576\u2013581 (2010).","journal-title":"Park. Relat. Disord."},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3934\/Neuroscience.2022027","volume":"9","author":"A Chakraborty","year":"2022","unstructured":"Chakraborty, A. & Diwan, A. Depression and Parkinson\u2019s disease: a Chicken-Egg story. AIMS Neurosci. 9, 479\u2013490 (2022).","journal-title":"AIMS Neurosci."},{"key":"1226_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"GM Halliday","year":"1990","unstructured":"Halliday, G. M. et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease. Ann. Neurol. 27, 373\u2013385 (1990).","journal-title":"Ann. Neurol."},{"key":"1226_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1226_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson, C. H., Ivanisevic, J. & Siuzdak, G. Metabolomics: beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17, 451\u2013459 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1226_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1021\/acs.chemrestox.0c00523","volume":"34","author":"Q Yan","year":"2021","unstructured":"Yan, Q. et al. High-resolution metabolomic assessment of pesticide exposure in Central Valley, California. Chem. Res. Toxicol. 34, 1337\u20131347 (2021).","journal-title":"Chem. Res. Toxicol."},{"key":"1226_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.aca.2020.10.038","volume":"1141","author":"MA Worheide","year":"2021","unstructured":"Worheide, M. A., Krumsiek, J., Kastenmuller, G. & Arnold, M. Multi-omics integration in biomedical research\u2014a metabolomics-centric review. Anal. Chim. Acta 1141, 144\u2013162 (2021).","journal-title":"Anal. Chim. Acta"},{"key":"1226_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","volume":"14","author":"Y Shao","year":"2019","unstructured":"Shao, Y. & Le, W. Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease. Mol. Neurodegener. 14, 3 (2019).","journal-title":"Mol. Neurodegener."},{"key":"1226_CR14","unstructured":"Troisi, J. et al. in Advances in Clinical Chemistry Vol. 104 (ed Gregory S. Makowski) 107\u2013149 (Elsevier, 2021)."},{"key":"1226_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13024-023-00694-5","volume":"18","author":"KC Paul","year":"2023","unstructured":"Paul, K. C. et al. Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson\u2019s disease. Mol. Neurodegener. 18, 100 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1226_CR16","doi-asserted-by":"publisher","unstructured":"Ostrakhovitch, E. A., Ono, K. & Yamasaki, T. R. Metabolomics in Parkinson\u2019s disease and correlation with disease state. Metabolites 15, https:\/\/doi.org\/10.3390\/metabo15030208 (2025).","DOI":"10.3390\/metabo15030208"},{"key":"1226_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.biopsych.2019.08.016","volume":"87","author":"M Bot","year":"2020","unstructured":"Bot, M. et al. Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol. Psychiatry 87, 409\u2013418 (2020).","journal-title":"Biol. Psychiatry"},{"key":"1226_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jad.2024.01.053","volume":"349","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Metabolomics on depression: a comparison of clinical and animal research. J. Affect Disord. 349, 559\u2013568 (2024).","journal-title":"J. Affect Disord."},{"key":"1226_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12035-024-04302-5","volume":"62","author":"P Singh","year":"2025","unstructured":"Singh, P. et al. Metabolomics in depression: what we learn from preclinical and clinical evidences. Mol. Neurobiol. 62, 718\u2013741 (2025).","journal-title":"Mol. Neurobiol."},{"key":"1226_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3892\/etm.2021.10443","volume":"22","author":"AM Ciobanu","year":"2021","unstructured":"Ciobanu, A. M. et al. Current advances in metabolomic studies on non-motor psychiatric manifestations of Parkinson\u2019s disease (Review). Exp. Ther. Med. 22, 1010 (2021).","journal-title":"Exp. Ther. Med."},{"key":"1226_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.parkreldis.2015.05.016","volume":"21","author":"Q Tong","year":"2015","unstructured":"Tong, Q. et al. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson\u2019s disease are associated with nonmotor symptoms. Park. Relat. Disord. 21, 882\u2013887 (2015).","journal-title":"Park. Relat. Disord."},{"key":"1226_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fnmol.2018.00257","volume":"11","author":"MX Dong","year":"2018","unstructured":"Dong, M. X. et al. Integrated analysis reveals altered lipid and glucose metabolism and identifies NOTCH2 as a biomarker for Parkinson\u2019s disease related depression. Fron.t Mol. Neurosci. 11, 257 (2018).","journal-title":"Fron.t Mol. Neurosci."},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.01.018","volume":"62","author":"A Duarte Folle","year":"2019","unstructured":"Duarte Folle, A., Paul, K. C., Bronstein, J. M., Keener, A. M. & Ritz, B. Clinical progression in Parkinson\u2019s disease with features of REM sleep behavior disorder: a population-based longitudinal study. Park. Relat. Disord. 62, 105\u2013111 (2019).","journal-title":"Park. Relat. Disord."},{"key":"1226_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells8010027","volume":"8","author":"H Xicoy","year":"2019","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. M. The role of lipids in Parkinson\u2019s disease. Cells 8, 27 (2019).","journal-title":"Cells"},{"key":"1226_CR25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1038\/s41380-020-0744-2","volume":"26","author":"P Zheng","year":"2021","unstructured":"Zheng, P. et al. The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression. Mol. Psychiatry 26, 2380\u20132392 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1226_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jare.2021.10.002","volume":"39","author":"T Tian","year":"2022","unstructured":"Tian, T. et al. Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice. J. Adv. Res. 39, 135\u2013145 (2022).","journal-title":"J. Adv. Res."},{"key":"1226_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2147\/NDT.S415141","volume":"19","author":"L Wen","year":"2023","unstructured":"Wen, L. et al. Metabolic alterations and related biological functions of post-stroke depression in ischemic stroke patients. Neuropsychiatr. Dis. Treat. 19, 1555\u20131564 (2023).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"1226_CR28","first-page":"463","volume":"30","author":"S Takahashi","year":"1976","unstructured":"Takahashi, S., Takahashi, R., Masumura, I. & Miike, A. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients. Folia Psychiatr. Neurol. Jpn 30, 463\u2013473 (1976).","journal-title":"Folia Psychiatr. Neurol. Jpn"},{"key":"1226_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Politis","year":"2015","unstructured":"Politis, M. & Niccolini, F. Serotonin in Parkinson\u2019s disease. Behav. Brain Res. 277, 136\u2013145 (2015).","journal-title":"Behav. Brain Res."},{"key":"1226_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue, C. et al. Tryptophan metabolism in health and disease. Cell Metab. 35, 1304\u20131326 (2023).","journal-title":"Cell Metab."},{"key":"1226_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997240","volume":"13","author":"M Fathi","year":"2022","unstructured":"Fathi, M. et al. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: a systematic review and meta-analysis. Front Immunol. 13, 997240 (2022).","journal-title":"Front Immunol."},{"key":"1226_CR32","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/mds.28202","volume":"35","author":"PL Heilman","year":"2020","unstructured":"Heilman, P. L. et al. Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson\u2019s disease. Mov. Disord. 35, 2028\u20132037 (2020).","journal-title":"Mov. Disord."},{"key":"1226_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","volume":"101","author":"ER Paul","year":"2022","unstructured":"Paul, E. R. et al. Peripheral and central kynurenine pathway abnormalities in major depression. Brain Behav. Immun. 101, 136\u2013145 (2022).","journal-title":"Brain Behav. Immun."},{"key":"1226_CR34","doi-asserted-by":"publisher","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","volume":"137","author":"JD Fernstrom","year":"2007","unstructured":"Fernstrom, J. D. & Fernstrom, M. H. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J. Nutr. 137, 1539S\u20131547S (2007). discussion 1548S.","journal-title":"J. Nutr."},{"key":"1226_CR35","first-page":"591","volume":"19","author":"H Fanet","year":"2021","unstructured":"Fanet, H., Capuron, L., Castanon, N., Calon, F. & Vancassel, S. Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry. Curr. Neuropharmacol. 19, 591\u2013609 (2021).","journal-title":"Curr. Neuropharmacol."},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.pnpbp.2005.06.021","volume":"29","author":"T Bottiglieri","year":"2005","unstructured":"Bottiglieri, T. Homocysteine and folate metabolism in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1103\u20131112 (2005).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1226_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80507-x","volume":"14","author":"N Yamada","year":"2024","unstructured":"Yamada, N. et al. Glycosylation changes of vWF in circulating extracellular vesicles to predict depression. Sci. Rep. 14, 29066 (2024).","journal-title":"Sci. Rep."},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10654-011-9574-5","volume":"26","author":"A Wang","year":"2011","unstructured":"Wang, A. et al. Parkinson\u2019s disease risk from ambient exposure to pesticides. Eur. J. Epidemiol. 26, 547\u2013555 (2011).","journal-title":"Eur. J. Epidemiol."},{"key":"1226_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.envint.2017.04.010","volume":"107","author":"S Narayan","year":"2017","unstructured":"Narayan, S., Liew, Z., Bronstein, J. M. & Ritz, B. Occupational pesticide use and Parkinson\u2019s disease in the Parkinson Environment Gene (PEG) study. Environ. Int. 107, 266\u2013273 (2017).","journal-title":"Environ. Int."},{"key":"1226_CR40","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/mds.20513","volume":"20","author":"GA Kang","year":"2005","unstructured":"Kang, G. A. et al. Clinical characteristics in early Parkinson\u2019s disease in a central California population-based study. Mov. Disord. 20, 1133\u20131142 (2005).","journal-title":"Mov. Disord."},{"key":"1226_CR41","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/bioinformatics\/btp291","volume":"25","author":"T Yu","year":"2009","unstructured":"Yu, T., Park, Y., Johnson, J. M. & Jones, D. P. apLCMS-adaptive processing of high-resolution LC\/MS data. Bioinformatics 25, 1930\u20131936 (2009).","journal-title":"Bioinformatics"},{"key":"1226_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jad.2015.05.059","volume":"184","author":"E Torbey","year":"2015","unstructured":"Torbey, E., Pachana, N. A. & Dissanayaka, N. N. Depression rating scales in Parkinson\u2019s disease: a critical review updating recent literature. J. Affect Disord. 184, 216\u2013224 (2015).","journal-title":"J. Affect Disord."},{"key":"1226_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/nu9070659","volume":"9","author":"J Kocot","year":"2017","unstructured":"Kocot, J., Luchowska-Kocot, D., Kielczykowska, M., Musik, I. & Kurzepa, J. Does vitamin C influence neurodegenerative diseases and psychiatric disorders?. Nutrients 9, 659 (2017).","journal-title":"Nutrients"},{"key":"1226_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2010.10.007","volume":"17","author":"AW Thompson","year":"2011","unstructured":"Thompson, A. W. et al. Diagnostic accuracy and agreement across three depression assessment measures for Parkinson\u2019s disease. Park. Relat. Disord. 17, 40\u201345 (2011).","journal-title":"Park. Relat. Disord."},{"key":"1226_CR45","first-page":"581","volume":"112","author":"M Perez-Enciso","year":"2003","unstructured":"Perez-Enciso, M. & Tenenhaus, M. Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum. Genet. 112, 581\u2013592 (2003).","journal-title":"Hum. Genet."},{"key":"1226_CR46","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1226_CR47","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong, J. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46, W486\u2013W494 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1226_CR48","doi-asserted-by":"publisher","first-page":"e1003123","DOI":"10.1371\/journal.pcbi.1003123","volume":"9","author":"S Li","year":"2013","unstructured":"Li, S. et al. Predicting network activity from high throughput metabolomics. PLoS Comput. Biol. 9, e1003123 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"1226_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/toxsci\/kfv198","volume":"148","author":"YM Go","year":"2015","unstructured":"Go, Y. M. et al. Reference standardization for mass spectrometry and high-resolution metabolomics applications to exposome research. Toxicol. Sci. 148, 531\u2013543 (2015).","journal-title":"Toxicol. Sci."},{"key":"1226_CR50","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1021\/acs.analchem.0c00338","volume":"92","author":"KH Liu","year":"2020","unstructured":"Liu, K. H. et al. Reference standardization for quantification and harmonization of large-scale metabolomics. Anal. Chem. 92, 8836\u20138844 (2020).","journal-title":"Anal. Chem."},{"key":"1226_CR51","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1021\/acs.analchem.6b01214","volume":"89","author":"K Uppal","year":"2017","unstructured":"Uppal, K., Walker, D. I. & Jones, D. P. xMSannotator: an R package for network-based annotation of high-resolution metabolomics data. Anal. Chem. 89, 1063\u20131067 (2017).","journal-title":"Anal. Chem."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01226-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01226-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01226-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:04:28Z","timestamp":1767967468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01226-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01226-2","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}